Filter
231
Filtered Results: 231
Text search:
T.
Rhodes
Featured
Recommendations
23
New Publications
21
Language
Document type
No document type
94
Studies & Reports
60
Guidelines
38
Manuals
19
Strategic & Response Plan
8
Fact sheets
4
Situation Updates
3
Resource Platforms
3
Brochures
1
Dashboards/Maps
1
Countries / Regions
Africa
8
Global
7
Latin America and the Carribbean
7
Western and Central Europe
7
Russia
7
South Africa
6
Ukraine
5
Eastern Europe
5
Germany
4
Uganda
4
Sierra Leone
3
Zimbabwe
3
Philippines
3
West and Central Africa
3
Spain
3
East and Southern Africa
3
Brazil
3
Angola
3
India
3
Kenya
2
Rwanda
2
Mozambique
2
USA
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
Sudan
2
Zambia
2
South Sudan
2
Indonesia
2
Nepal
1
Timor Leste/ East Timor
1
Thailand
1
Benin
1
Chile
1
Cameroon
1
Syria
1
Burkina Faso
1
Peru
1
Guinea
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
Côte d’Ivoire / Ivory Coast
1
Bangladesh
1
Sri Lanka
1
Yemen
1
Chad
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
47
Clinical Guidelines
13
Public Health
11
Women & Child Health
7
Key Resources
5
Pharmacy & Technologies
3
Toolboxes
NTDs
43
HIV
31
COVID-19
30
Mental Health
27
TB
15
Pharmacy
12
Planetary Health
9
Disability
8
NCDs
6
AMR
6
Refugee
4
Caregiver
4
Rapid Response
2
Health Financing Toolbox
2
Global Health Education
2
Natural Hazards
1
Ebola & Marburg
1
Social Ethics
1
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the disease and both subspecies of the parasite, T.b. gambiense and T.b. rhodesiense. T.b. rhodesiense is ...
The Global Health Observatory
Harm reduction: evidence, impacts and challenges
-10-
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in...
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei gambiense accounts for 98% of all cases of African trypanosomiasis, and T. brucei rhodesiense account...
More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form)
Human African trypanosomiasis (HAT), or sleeping sickness, transmitted by tsetse flies in sub-Saharan Africa, is a life-threatening disease that afflict...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Human African trypanosomiasis (HAT), or sleeping sickness, is caused by trypanosome parasites that are transmitted by tsetse flies. HAT is found only in sub-Saharan Africa. Two subspecies of Trypanosoma brucei cause disease: T. b. gambiense in West and Central Africa, and T. b. rhodesiense in East A...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
Guidelines for the treatment of human African trypanosomiasis. Web Annex A. Commissioned by WHO Cochrane Response
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
Having established the goal of eliminating transmission of gambiense human African trypanosomiasis (g-HAT) to humans, the HAT-e-TAG considered which elements should be developed to assess this goal.
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
Supportive supervision is considered critical to community health worker programme performance, but there is relatively little understanding of how it can be sustainably done at scale. Supportive supervision is a holistic concept that encompasses three key functions: management (ensuring performance...
EMCDDA Insights - 11
Accessed: 14.03.2019
